---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-066974"
form_type: "8-K"
ticker: "LIMN"
cik: "0001971387"
company_name: "Liminatus Pharma, Inc."
filed_at: "2026-05-27T20:30:41+00:00"
generated_at: "2026-05-27T20:33:45.997674+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Liminatus Pharma receives Nasdaq delisting notice; appeals filed

## Summary
- On May 20, 2026, Nasdaq notified Liminatus Pharma it failed to regain compliance with $50M MVLS and $15M MVPHS requirements.
- Trading suspension of common stock (LIMN) and warrants (LIMNW) set for May 29, 2026 unless appeal filed by May 27, 2026.
- On May 26, 2026, Company requested a hearing before Nasdaq Hearings Panel, which stays delisting pending hearing.
- Company previously disclosed non-compliance on Nov 19, 2025 and had 180-day cure period ending May 18, 2026.

## SEC filing metadata
- accession: 0001104659-26-066974
- form_type: 8-K
- ticker: LIMN
- cik: 0001971387
- company_name: Liminatus Pharma, Inc.
- filed_at: 2026-05-27T20:30:41+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 3.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1971387/000110465926066974/0001104659-26-066974-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1971387/000110465926066974/tm2615785d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-066974
- JSON: https://secwatch.observer/filing/0001104659-26-066974.json
- Plain text: https://secwatch.observer/filing/0001104659-26-066974.txt

## Source-grounded claims
- claim_id: 4bed6402d8e2d89d0da71ced1007f60871bb510b
  claim: Liminatus Pharma, Inc. received a nasdaq delisting notice notice regarding market value (rules 5450(b)(2)(A), 5450(b)(2)(C)).
  evidence_excerpt: May 20, 2026, the Company received a notice from Nasdaq stating that the Company had not regained compliance with the MVLS Rule and the MVPHS Rule. Accordingly, its securities will be delisted from The Nasdaq Global Mark
  evidence_url: https://www.sec.gov/Archives/edgar/data/1971387/000110465926066974/0001104659-26-066974-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.